BioGenex designs, develops and commercializes molecular pathology systems for cancer diagnosis, prognosis, precession medicine and life science research. The recent introduction of our cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are a game changer and envy of the industry. Our fully-automated molecular pathology workstations are the most advanced system available globally. BioGenex prides itself on delivering cutting edge technology, years ahead of its competition, providing the finest systems for immunohistochemistry (IHC), In Situ hybridization (ISH), FISH, Special stains and In Situ PCR. BioGenex unconditionally guarantees performance of its systems and products: antibodies, probes, antigen retrieval, detection systems and histology stains. We are committed to provide quality systems and best in class customer care.

Facts and Figures

Mission Statement

Our Core Values

At BioGenex, our performance-oriented culture and customer-centric approach are the foundation of our success. Built upon that foundation, we have erected six pillars of business – they define who we are and guide every decision we make.

• Empowerment: Our employees are empowered to make decisions that help improve our products, services and the company.
• Dedication: Our success is due to the dedication and passion brought to work every day by our employees.
• Collaboration: Our success stems from promoting teamwork and working together toward a common goal — collaboration is a cornerstone of our work culture.
• Customer Focus: The customer’s interest is our top priority. Large or small, high volume or low, we build long term customer relationships through attentiveness, excellence, fairness and superior performance.
• Innovation: Our products are created by continually challenging ourselves to seek alternative solutions to complex problems that customers may face. Innovation is a key driver for our growth.
• Integrity: We “do the right thing” and believe in being responsive, straight-forward and committed to our customers.

Our History

BioGenex was founded in 1981 in San Ramon, California. The company was established with a firm resolution to become a global molecular medicine company providing affordable solutions for life sciences research and personalized medicine.

In 1991, BioGenex acquired American Bionetics (ABN) and turned their DNA/RNA reagent business into a profitable venture within six months. Since then, the company has launched a series of automated staining systems and a full suite of innovative histology products.

Today, BioGenex is a global market leader in molecular pathology providing customer-centric solutions for complete automation of cell and tissue staining. Through its cutting-edge and patented technologies, the company has transformed the practice of slide-based staining in many molecular pathology laboratories.

Early, affordable and accurate diagnosis at the molecular level has resulted in a higher quality of life for cancer patients. BioGenex takes pride in making a difference through its innovative products and superior customer service.

BioGenex Timeline

2010s
2015 – Xmatrx offered in situ PCR and miRNA assays
2015 – Dedication of 100,000 sq.ft. Regional Center of Excellence in Hyderabad, India
2014 – Introduction of Xmatrx ELITE, NANO and MINI systems
2014 – BioGenex S.R.L., a wholly owned subsidiary of BioGenex, established in Milan, Italy
2014 – Introduction of multiple Nucleic Acid Detection (NAD) products
2010 – Agency office open in Shanghai, China

2000s
2009 – Abbott and BioGenex extended Xmatrx technology co-development and distribution agreement
2009 – Introduction of eFISHiency, fully automated FISH system powered by Abbot
2006 – Hyderabad, India subsidiary established
2005 – Introduction of Super Sensitive Polymer-HRP detection system
2005 – Introduction of Xmatrx staining system
2004 – BioGenex entered agreement with Abbott to co-develop FISH automation
2001 – Introduction of i6000 staining system

1990s
1999 – Introduction of special stain kits to OptiMax Plus staining system
1996 – Introduction of Advanced OptiMax Plus staining system
1994 – Introduction of first generation of OptiMax Plus staining system
1994 – Introduction of DNA probe product line for in situ hybridization
1991 – Acquisition of American Bionetics (ABN) was completed
1990 – Introduction of MultiLink IHC detection system

1980s
1989 – Introduction of BioGenex antigen retrieval products
1981 – Company founded in San Ramon, California

Quality Policy

BioGenex is committed to the design, manufacture and distribution of safe, effective and reliable products. To achieve our quality goal, we will:

• Meet or exceed internal and external customer needs
• Meet or exceed applicable worldwide quality standards and regulatory requirements
• Continually motivate and develop our employees to improve our processes and quality system